A Randomised Comparison of Anastrozole Commenced Before and Continued During Adjuvant Radiotherapy for Breast Cancer Versus Anastrozole and Subsequent Anti-Oestrogen Therapy Delayed Until After Radiotherapy.

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 12 Apr 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Anastrozole (Primary)
Indications Breast cancer
Focus Therapeutic Use
Acronyms STARS

Most Recent Events

05 Sep 2018 Planned End Date changed from 1 Dec 2024 to 31 Dec 2026.
24 Jan 2017 Status changed from recruiting to active, no longer recruiting.
16 May 2013 Planned end date changed from 1 May 2015 to 1 Dec 2024 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight